Reaktionsgleichung
[CH3:1][C:2]([N:10]1[CH:14]=[C:13]([NH:15][C:16](=[O:22])[CH:17]([NH2:21])[CH2:18][CH2:19][CH3:20])[N:12]=[CH:11]1)([CH3:9])[CH2:3][N:4]1[CH2:8][CH2:7][CH2:6][CH2:5]1.[OH:23][C@@H:24]([C:28]([CH3:31])([CH3:30])[CH3:29])[C:25](O)=[O:26]>>[CH3:1][C:2]([N:10]1[CH:14]=[C:13]([NH:15][C:16](=[O:22])[CH:17]([NH:21][C:25](=[O:26])[CH:24]([OH:23])[C:28]([CH3:31])([CH3:30])[CH3:29])[CH2:18][CH2:19][CH3:20])[N:12]=[CH:11]1)([CH3:9])[CH2:3][N:4]1[CH2:8][CH2:7][CH2:6][CH2:5]1Komponenten
3
Edukt 2
Produkt 1
Versuchsvorschrift
2-Amino-pentanoic acid [1-(1,1-dimethyl-2-pyrrolidin-1-yl-ethyl)-1H-imidazol-4-yl]-amide was coupled with (S)-2-hydroxy-3,3-dimethyl-butyric acid to afford the title compound: C13 NMR (100 MHz, CDCl3) 12.7, 18.9, 22.8, 25.2, 25.4, 33.9, 34.8, 53.0, 56.8, 60.5, 63.3, 79.0, 107.5, 131.2, 171.8, 174.8; MS m/z 422.4 (M+1).
Quellen und Nachweise
- ORD-Eintrag
- ord-3642d66161e240318592228019a703b8
- Quelldatensatz
- uspto-grants-2008_03
- Patentnummer
- US07342118B2
Verknüpfte Notizen
Wird geladen…